Our findings suggest that low CCT2 expression may be responsible for the autophagy suppression in Alzheimer’s disease, providing an accurate explanation for its pathogenesis and new targets and small molecule inhibitors for its treatment. This evidence concerns the gene CCT2 and early-onset autosomal dominant Alzheimer disease.